Results 21 to 30 of about 622,897 (403)
Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
Background The etiological agent for the coronavirus illness outbreak in 2019–2020 is a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), whereas coronavirus disease pandemic of 2019 (COVID-19) has ...
Soumya Gulab Katre +6 more
doaj +1 more source
Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic
Context.—The novel coronavirus disease 2019 (COVID-19) pandemic is significantly changing methodologic approaches in all branches of the health system. From a forensic point of view, this event is partly changing the manner in which forensic pathologists and all those who work in autopsy services operate, but above all, it is changing the patterns ...
Aquila, Isabella +11 more
openaire +4 more sources
Background Patients with severe acute respiratory syndrome coronavirus 2 infection show various clinical manifestations, including neurological .
Triana Ayuningtyas +4 more
doaj +1 more source
Role of Eyes and Eyes Protection Amidst SARS-CoV-2 Infection
Severe Acute Respiratory Syndrome Coronavirus 2 pandemic has infected millions of people. The conjunctival epithelium is easily exposed to infectious droplets and body fluids making eyes a potential route and reservoir of the infection.
Bibechan Thapa
doaj +1 more source
Secretion of severe acute respiratory syndrome coronavirus 2 in urine [PDF]
Purpose of review Despite the plethora of publications discussing the severe respiratory coronavirus 2 (SARS-CoV-2), evidence of viral secretion in urine is sparse. Recent findings We could identify 34 publications including a total of 2172 patients.
Brönimann S. +5 more
openaire +2 more sources
Background: Despite investigating coronavirus among respiratory tract infected cases is a top priority to prevent further transmission, severe acute respiratory syndrome coronavirus 2 positivity among this group of patients remains unexplored in resource-
Abdi Birhanu +4 more
doaj +1 more source
Background The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first broke out in Wuhan (China) and subsequently spread worldwide. Chloroquine has been sporadically used in treating SARS-CoV-2 infection.
Xueting Yao +14 more
semanticscholar +1 more source
Repurposing Interleukin-6 Inhibitors to Combat COVID-19. [PDF]
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a pandemic with major implications across the world. One of the most frequent causes of death from SARS-CoV-2 is fatal pneumonia from coronavirus disease 2019 (COVID-19), which is associated
Kato, Shumei, Kurzrock, Razelle
core +1 more source
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Severe acute respiratory syndrome coronavirus 2 is the causative agent of the ongoing coronavirus disease pandemic. Initial estimates of the early dynamics of the outbreak in Wuhan, China, suggested a doubling time of the number of infected persons of 6 ...
S. Sanche +5 more
semanticscholar +1 more source
Introduction: The response to vaccination against the virus that causes severe acute respiratory infection syndrome coronavirus 2 is lower in renal transplant recipients than in the general population.
Camilo Montero +7 more
doaj +1 more source

